SCHEMBL14001021

SCHEMBL14001021

CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)cc3)c(=O)n2C1c1cccc(O)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 1/20 0.74
PTPN22 Q9Y2R2 4/20 0.72
PTPN7 P35236 4/20 0.69
DUSP3 P51452 4/20 0.69
DUSP6 Q16828 1/20 0.69
MEN1 O00255 9/20 0.68
KMT2A Q03164 9/20 0.68
ALDH1A1 P00352 3/20 0.68
NPSR1 Q6W5P4 3/20 0.68
CSNK2A2 P19784 2/20 0.66
CSNK2B P67870 2/20 0.66
CSNK2A1 P68400 2/20 0.66
TNF P01375 1/20 0.65
IL6 P05231 1/20 0.65
POLB P06746 4/20 0.62
USP2 O75604 2/20 0.62
MAPT P10636 2/20 0.62
HPGD P15428 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
HSD17B10 Q99714 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14001421 0.91 PTPN22 (0.85) CDC25BPTPN22PTPN7DUSP3DUSP6
SCHEMBL14001022 0.90 CSNK2A2 (0.79) CDC25BPTPN22PTPN7DUSP3DUSP6
SCHEMBL14001087 0.88 CDC25B (0.74) CDC25BPTPN22PTPN7DUSP3DUSP6
SCHEMBL4668190 0.86 MEN1 (0.82) PTPN22PTPN7DUSP3DUSP6MEN1
SCHEMBL4668189 0.86 MEN1 (0.82) PTPN22PTPN7DUSP3DUSP6MEN1
SCHEMBL13855916 0.86 PTPN22 (0.83) CDC25BPTPN22PTPN7DUSP3DUSP6
SCHEMBL4669372 0.85 CDC25B (1.00) CDC25BPTPN22PTPN7DUSP3DUSP6
SCHEMBL4669374 0.85 CDC25B (1.00) CDC25BPTPN22PTPN7DUSP3DUSP6
SCHEMBL14103312 0.84 MEN1 (0.80) CDC25BPTPN22PTPN7DUSP3MEN1
SCHEMBL4669321 0.84 PTPN22 (0.74) CDC25BPTPN22PTPN7DUSP3DUSP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008149311-A1 USE OF DERIVATIVES OF 3-OXO-2,3-DIHYDRO-5H-THIAZOLOF[3,2-A]PYRIMIDINE OR OF 3-OXO-2,3-DIHYDRO-5H-SELENAZOLO[3,2-A]PYRIMIDINE OR OF 3-OXO-1,2,3-TRIHYDRO-5H-IMIDAZOLO[1,2-A]PYRIMIDINE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE TREATMENT OF CANCER INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2008-12-11 WO disclosed